Quality by Design risk assessments supporting approved antibody products
Open Access
- 9 September 2016
- journal article
- editorial material
- Published by Taylor & Francis Ltd in mAbs
- Vol. 8 (8), 1435-1436
- https://doi.org/10.1080/19420862.2016.1232218
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Introduction to the application of QbD principles for the development of monoclonal antibodiesBiologicals, 2016
- Determination of critical quality attributes for monoclonal antibodies using quality by design principlesBiologicals, 2016
- Process characterization and Design Space definitionBiologicals, 2016
- Establishing a control system using QbD principlesBiologicals, 2016
- Foreword: Quality by Design for monoclonal antibodies: Description of an integrated systemBiologicals, 2016
- Regulatory Considerations for Implementation of the QbD Paradigm for Biologics: Laying the Foundation for Product and Process Lifecycle ManagementPublished by Springer Science and Business Media LLC ,2015
- Lessons Learned from Monoclonal Antibody Applications to the Office of Biotechnology Products Quality by Design Pilot ProgramAAPS Advances in the Pharmaceutical Sciences Series, 2015
- Implementing quality by design for biotech products: Are regulators on track?mAbs, 2015
- Quality by design for biopharmaceuticalsNature Biotechnology, 2009
- Considerations for Biotechnology Product Quality by DesignPublished by Wiley ,2008